China channel feed

Fo­s­un Phar­ma to re­ceive $100M+ via World Bank for fa­cil­i­ty in Ivory Coast

2 days ago
Pharma
Manufacturing

FDA in­spec­tion of Chi­na-based site mak­ing Co­herus' po­ten­tial new can­cer drug ends with three ob­ser­va­tions

Last week
FDA+

Chi­na's mar­ket reg­u­la­tor fines, con­fis­cates rev­enue from phar­mas for mo­nop­o­liz­ing APIs for ep­i­neph­rine

Last week
R&D

C4 Ther­a­peu­tics gets $35M from Bet­ta Phar­ma­ceu­ti­cals to de­vel­op and mar­ket NSCLC drug in Chi­na

Last week
Deals
R&D

XtalPi inks $250M pact with Lil­ly af­ter Pfiz­er suc­cess

Last week
Deals
AI

In­novent show­cas­es topline PhII win for high-dose obe­si­ty drug in Chi­na

5 weeks ago
R&D

Roche hands Chi­nese biotech $70M for HER2 drug that can go to the brain

Last month
Deals

Ei­sai’s can­cer drug Halaven at the cen­ter of $2B pact with Bliss­Bio, like its Bris­tol My­ers ADC deal

Last month
Deals
Pharma

Chi­nese biotech start­up adds $315M to the bank af­ter bring­ing 5 Take­da drugs to its fold

Last month
Financing

Pyra­mid inks TROP2 pact with Chi­na biotech to fol­low suit of Gilead, As­traZeneca-Dai­ichi Sankyo

Last month
Startups
Deals

Phar­maron ex­pand­ing Liv­er­pool man­u­fac­tur­ing fa­cil­i­ty with a $186M+ price tag

2 months ago
Manufacturing

Brii Bio­sciences stops man­u­fac­tur­ing Covid-19 an­ti­body com­bo, plans to with­draw EUA re­quest

2 months ago
R&D
Coronavirus

F-star's sale to Chi­nese buy­er cleared by CFIUS fol­low­ing months of holdup

3 months ago
Deals

Shang­hai's Ab­bisko out-li­cens­es EGFR can­di­date in po­ten­tial­ly nine-fig­ure deal

3 months ago
Deals

Scoop: As­cle­tis' NASH sub­sidiary scraps US PhII tri­al in fa­vor of Chi­na

3 months ago
R&D

In push to ex­pand its CAR-T ther­a­pies to US, Chi­na biotech Ori­cell rais­es ad­di­tion­al $45M

3 months ago
Financing

Kin­nate en­gi­neers $24M deal to win con­trol of Chi­na joint ven­ture back from Or­biMed, Fore­site

3 months ago
Deals

Up­dat­ed: Take­da bets $400M cash on col­orec­tal can­cer drug in boost to Chi­na's Hutchmed

4 months ago
Deals

BeiGene's Brukin­sa wins CLL ap­proval af­ter top­ping Im­bru­vi­ca in head-to-head tri­al

4 months ago
Pharma
FDA+

Ready to ex­pand, Gen­Script rais­es $224M for CD­MO fo­cused on an­ti­bod­ies, cell and gene ther­a­pies

4 months ago
Financing
Outsourcing

Q&A: Can in­haled vac­cines mount come­back for one-time leader in Chi­na's Covid race?

4 months ago
People

WuXi inks $1.5B GSK pact, a big biobuck bet but a blip in bil­lions lost from US un­ver­i­fied list

5 months ago
Financing
Deals

High­T­ide Ther­a­peu­tics rides NASH R&D wave with a $107M raise

5 months ago
Financing
Startups

Scoop: Bing Yao’s Ar­riVent lin­ing up $145M raise, af­ter $150M de­but in 2021

5 months ago
Financing
Startups
1234 Next page Last page
A service from the Financial Times